Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Events, Stroke, and Mortality in Patients with Type 2 Diabetes

被引：0
作者：
Kawada, Tomoyuki [1 ]
机构：
[1] Nippon Med Sch, Dept Hyg & Publ Hlth, 1 1 5 Sendagi Bunkyo Ku, Tokyo 1138602, Japan
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 2023年 / 37卷 / 04期
关键词：
OUTCOMES;
D O I：
10.1007/s10557-022-07374-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：619 / 620
页数：2
相关论文
共 50 条
[11]   Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention [J].
Reid, Jessica ;
Rana, Khyatiben ;
Niman, Stephanie ;
Sheikh-Ali, Mae ;
Lewis, Todd ;
Choksi, Rushab R. ;
Goldfaden, Rebecca F. .
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (05) :419-429
[12]   Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a magic potion to reduce heart failure? [J].
Pafili, K. ;
Papanas, N. .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) :693-695
[13]   The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure, Regardless of Diabetes Status: Focus on Cardiovascular Disease [J].
Ferrari, Filipe ;
Martins, Vitor M. ;
Scheffel, Rafael S. ;
da Silveira, Anderson D. ;
Motta, Marcelo Trotte ;
Moriguchi, Emilio H. ;
Santos, Raul D. ;
Stein, Ricardo .
ANNALS OF PHARMACOTHERAPY, 2021, 55 (10) :1267-1275
[14]   Pathophysiological explanation of cardiovascular benefits of sodium-glucose cotransporter-2 inhibitors by neurotrophic theory [J].
Hristova, Mariyana .
MEDICAL HYPOTHESES, 2017, 102 :61-64
[15]   Diving into the unknown: sodium-glucose cotransporter-2 inhibitors in heart failure without diabetes [J].
Seferovic, Petar M. ;
Seferovic, Jelena P. ;
Polovina, Marija M. .
EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (07) :874-876
[16]   Use of sodium-glucose cotransporter 2 inhibitors in older patients with type 2 diabetes mellitus [J].
Kambara, Takahiro ;
Shibata, Rei ;
Osanai, Hiroyuki ;
Nakashima, Yoshihito ;
Asano, Hiroshi ;
Sakai, Kazuyoshi ;
Murohara, Toyoaki ;
Ajioka, Masayoshi .
GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (01) :108-114
[17]   Effect of Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase 4 Inhibitors on Cardiovascular Function in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease [J].
Lee, Sook Jung ;
Lee, Kook Hyung ;
Oh, Hyun Geong ;
Seo, Hye Ji ;
Jeong, Soo Jin ;
Kim, Chong Hwa .
JOURNAL OF OBESITY & METABOLIC SYNDROME, 2019, 28 (04) :254-261
[18]   Sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection? [J].
Snaith, Jennifer R. ;
Greenfield, Jerry R. .
MEDICAL JOURNAL OF AUSTRALIA, 2022, 217 (03) :126-128
[19]   Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study [J].
Fu, Edouard L. L. ;
D'Andrea, Elvira ;
Wexler, Deborah J. ;
Patorno, Elisabetta ;
Paik, Julie M. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (05) :592-601
[20]   Benefits of Taking Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: A Systematic Review [J].
Sarker, Aditi ;
Ramesh, Adarsh Srinivas ;
Munoz, Carlos ;
Jamil, Dawood ;
Tran, Hadrian Hoang-Vu ;
Mansoor, Mafaz ;
Butt, Samia Rauf ;
Satnarine, Travis ;
Ratna, Pranuthi ;
Hamid, Pousette .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
12345